In another study, Bouchi et al. [23] discovered that patients with type 2 diabetes treated with insulin may be at a lower risk for the loss of skeletal muscle mass in the lower extremities compared with those who do not receive insulin treatment. The gene discussed is INS; the disease is type 2 diabetes mellitus.